Mr. Karnani has more than 15 years of leadership experience in the life sciences industry. Over the course of nearly a decade at Horizon Therapeutics, Mr. Karnani held leadership positions spanning ...

We've raised our fair value estimate to $322 per share from $309 following Air Products' fiscal 2024 fourth-quarter earnings release, mostly due to the time value of money. For full-year fiscal 2025, ...

The best luxury gifts for women are thoughtful, useful, and beautiful. We've curated the most luxurious fashion, beauty, and ...

Paul Long - CEO - Little Green Pharma Limited (ASX:LGP) produces and supplies medicinal cannabis products, including oils and ...

Executive Chairman - BPH Global Limited (ASX:BP8) is a diversified biotechnology company focused on the health and energy ...

Total revenue of $3.24 billion, down 5.7% (down 5.6% on an organic basis(1)) Diluted earnings per share was $0.23 vs. $0.49 in the prior year quarter; ...

Today, Devon is among the lowest-cost providers on the US shale cost curve, along with Diamondback Energy and EOG Resources. Devon’s reconstituted portfolio is buoyed by its presence in the Delaware, ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsLarry Heaton – Chief Executive OfficerMike ...

Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced that ...

In my presentation, I mentioned the migration of non-intentionally added substances from plastic packaging: Volatile and semi-volatile organic substances, including surfactants ... a member you will ...